Therapeutic Apheresis and Dialysis
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.5 | Q3 | 32.8% | 0.453 | Q3 | 57.4% |
| 2024 | 1.2 | Q3 | 32.8% | 0.426 | Q3 | 56.9% |
| 2023 | 1.5 | Q3 | 38.9% | 0.419 | Q3 | 59.2% |
| 2022 | 1.9 | Q4 | 42.4% | 0.505 | Q2 | 66.6% |
| 2021 | 2.2 | Q3 | 46.2% | 0.496 | Q2 | 66.8% |
| 2020 | — | — | 0.415 | Q3 | 60.6% | |
| 2019 | — | — | 0.365 | Q3 | 58.4% | |
| 2018 | — | — | 0.571 | Q2 | 69.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-9979
ISSN
1744-9987
region
Western Europe
coverage
2003-2026